Related Experiment Video
Updated: Jun 7, 2026

Preparation of Naringenin Solution for In Vivo Application
Published on: August 10, 2021
NO-donating Bergenin derivatives with enhanced anti-inflammatory activity
Enshang Yuan1, Qi Deng2, Na Li1
1State Key Laboratory of Natural Medicines, Department of Natural Medicinal Chemistry, School of Traditional Chinese Pharmacy, China Pharmaceutical University, 639 Longmian Avenue, Nanjing 211198, China.
None:
Ten new nitric oxide (NO)-donating Bergenin derivatives were designed, synthesized, and evaluated for their anti-inflammatory activity. Distinguished by its superior safety profile, a single furoxan moiety conjugated hybrid I8 was selected for mechanistic studies. The results revealed that the anti-inflammatory effects of I8 is probably related to the negative feedback inhibition of iNOS expression by promoting NO release, as well as the inhibition of the pro-inflammatory cytokines (TNF-α, IL-6) levels. These findings provide direct evidence supporting the hypothesis that BG-NO hybrids exert enhanced anti-inflammatory effects via NO signaling, identifying I8 as a promising lead compound for further development.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms: